LianBio
LIANY- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001831283
No open-market purchases or sales by LianBio insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $1.00K in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in LianBio as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 44
- 0 vs. Q2 2022
- Shares held
- 84.0M
- −2.57M (−3.0%) vs. Q2 2022
- Total value
- $168.0M
- −$19.1M (−10.2%) vs. Q2 2022
- New holders
- 6
- 18 more added
- Sold out
- 6
- 6 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LIANY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $1.00K |
| Q1 2026 | 1 | $1.00K |
| Q4 2025 | 1 | $1.00K |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 1 | $5.00K |
| Q1 2025 | 1 | $2.00K |
| Q4 2024 | 2 | $42.1K |
| Q3 2024 | 2 | $47.3K |
| Q2 2024 | 2 | $50.5K |
| Q1 2024 | 3 | $49.2K |
| Q4 2023 | 29 | $377.3M |
| Q3 2023 | 38 | $117.7M |
| Q2 2023 | 39 | $182.9M |
| Q1 2023 | 36 | $157.1M |
| Q4 2022 | 40 | $133.3M |
| Q3 2022 | 44 | $168.0M |
| Q2 2022 | 44 | $187.1M |
| Q1 2022 | 37 | $318.6M |
| Q4 2021 | 36 | $550.5M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding LianBio; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Perceptive Advisors LLC | 57,558,451 | $115.1M | 3.35% | +998,240+1.8% | Added |
| VR Adviser, LLC | 5,378,341 | $10.8M | 1.66% | 00.0% | Unchanged |
| Viking Global Investors LPSuperinvestorViking Global Investors | 3,564,173 | $7.09M | 0.03% | 00.0% | Unchanged |
| Tybourne Capital Management (HK) Ltd | 3,303,573 | $6.61M | 0.64% | −10,600−0.3% | Reduced |
| Price T Rowe Associates Inc | 2,822,857 | $5.62M | 0.00% | +695,979+32.7% | Added |
| Vida Ventures Advisors, LLC | 2,282,084 | $4.56M | 4.10% | 00.0% | Unchanged |
| Wellington Management Group LLP | 1,032,084 | $2.05M | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 1,023,107 | $2.05M | 0.00% | −8,976−0.9% | Reduced |
| SCHF (Gpe), LLC | 937,500 | $1.88M | 2.47% | 00.0% | Unchanged |
| Citadel Advisors LLC | 840,169 | $1.67M | 0.00% | +2,996+0.4% | Added |
| Hudson Bay Capital Management LP | 713,743 | $1.42M | 0.01% | 00.0% | Unchanged |
| Citigroup Inc | 707,336 | $1.41M | 0.00% | +258,817+57.7% | Added |
| Affinity Asset Advisors, LLC | 550,000 | $1.09M | 0.50% | +100,000+22.2% | Added |
| Alyeska Investment Group, L.P. | 429,186 | $858.0K | 0.01% | +100,000+30.4% | Added |
| Renaissance Technologies LLC | 315,000 | $630.0K | 0.00% | +254,100+417.2% | Added |
| Logos Global Management LP | 307,908 | $616.0K | 0.08% | −86,578−21.9% | Reduced |
| Barclays PLC | 268,400 | $537.0K | 0.00% | +268,400 | New |
| Millennium Management LLC | 210,390 | $419.0K | 0.00% | +97,189+85.9% | Added |
| Casdin Capital, LLC | 206,415 | $411.0K | 0.03% | 00.0% | Unchanged |
| Marshall Wace, LLP | 206,497 | $410.0K | 0.00% | −16,894−7.6% | Reduced |
| TD Asset Management Inc | 178,519 | $359.0K | 0.00% | +23,600+15.2% | Added |
| Victory Capital Management Inc | 173,460 | $347.0K | 0.00% | 00.0% | Unchanged |
| 22NW, LP | 141,223 | $282.0K | 0.16% | 00.0% | Unchanged |
| Gsa Capital Partners LLP | 125,972 | $252.0K | 0.03% | +29,388+30.4% | Added |
| MYDA Advisors LLC | 120,000 | $240.0K | 0.13% | 00.0% | Unchanged |
| Manufacturers Life Insurance Company, The | 117,484 | $236.1K | 0.00% | +39,700+51.0% | Added |
| Cornercap Investment Counsel Inc | 81,830 | $163.0K | 0.03% | +29,690+56.9% | Added |
| Thrivent Financial for Lutherans | 80,959 | $162.0K | 0.00% | +1,739+2.2% | Added |
| Alps Advisors Inc | 58,490 | $116.0K | 0.00% | −5,738−8.9% | Reduced |
| Morgan Stanley | 55,146 | $110.0K | 0.00% | +54,145+5,409.1% | Added |
| HighTower Advisors, LLC | 39,000 | $78.0K | 0.00% | +20,100+106.3% | Added |
| Old Well Partners, LLC | 32,200 | $64.0K | 0.05% | 00.0% | Unchanged |
| Powell Investment Advisors, LLC | 30,000 | $60.0K | 0.04% | +30,000 | New |
| Vident Investment Advisory, LLC | 28,616 | $57.0K | 0.00% | +8,703+43.7% | Added |
| Susquehanna International Group, LLP | 23,245 | $46.0K | 0.00% | +23,245 | New |
| Tower Research Capital LLC (TRC) | 20,773 | $41.0K | 0.00% | +19,616+1,695.4% | Added |
| Bailard, Inc. | 19,606 | $39.0K | 0.00% | −27,991−58.8% | Reduced |
| Goldman Sachs Group Inc | 12,157 | $24.0K | 0.00% | +12,157 | New |
| Alliancebernstein L.P. | 11,500 | $23.0K | 0.00% | 00.0% | Unchanged |
| Commonwealth Equity Services, LLC | 10,830 | $21.0K | 0.00% | 00.0% | Unchanged |
| Raymond James & Associates | 10,650 | $21.0K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 8,177 | $16.0K | 0.00% | +7,174+715.3% | Added |
| UBS Group AG | 1,247 | $2.00K | 0.00% | +1,247 | New |
| JPMorgan Chase & Co | 178 | $0 | 0.00% | +178 | New |
| Ra Capital Management, L.P. | 0 | $0 | 0.00% | −4,622,574−100.0% | Sold out |
| Farallon Capital Management, L.L.C. | 0 | $0 | 0.00% | −500,000−100.0% | Sold out |
| Altium Capital Management LP | 0 | $0 | 0.00% | −315,191−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −32,300−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −11,740−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −11,900−100.0% | Sold out |